Vena Caval Filters in Pulmonary Embolism

 

 Buy Article Permissions and Reprints

ABSTRACT

Since the early 1900s, surgical interruption of the inferior vena cava (IVC) has been utilized in the management of venous thromboembolism (VTE). With the advent of newer-generation percutaneous devices in the late 1970s, their use and indications have expanded. The literature to support their efficacy, however, is limited to several case series and a single randomized controlled trial. Despite this, some have advocated the use of IVC filters as primary treatment of VTE in certain patient populations. In addition, there has been a large amount of interest in their use as prophylaxis against pulmonary embolism (PE) in high-risk patients. In the past 10 years, we have also seen the development and initial use of temporary devices, although their role in the management of this disease is even less certain. This article will review the recent literature on efficacy, complications, and indications for the use of IVC filters in the prevention and treatment of PE.

REFERENCES

• 1 Shilz R J, Wirth J. Use of vena cava filters in the management of venous thromboembolic disease. PCCU (On line) 1999; 14(3)
  Google Scholar
• 2 Albert J, Smith R, Carlson J. Mortality in patients treated for pulmonary embolism.  JAMA . 1976;  236 1477-1480
  CrossrefPubMedGoogle Scholar
• 3 Whitehill T A. Current vena cava filter devices and results.  Semin Vasc Surg . 2000;  13(3) 204-212
  PubMedGoogle Scholar
• 4 Ferris E J, McCowan T C, Carver D K, McFarland D R. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients [see comments].  Radiology . 1993;  188(3) 851-856
  CrossrefPubMedGoogle Scholar
• 5 Greenfield L J, Michan B A. Twelve-year clinical experience with the Greenfield vena caval filter.  Surgery . 1988;  104 706-712
  PubMedGoogle Scholar
• 6 Athanasoulis C A, Kaufman J A, Halpern E F, Waltman A C, Geller S C, Fan C. Inferior vena caval filters: review of a 26-year single-center clinical experience.  Radiology . 2000;  216(1) 54-66
  CrossrefPubMedGoogle Scholar
• 7 Ballew K A, Philbrick J T, Becker D M. Vena cava filter devices.  Clin Chest Med . 1995;  16(2) 295-305
  PubMedGoogle Scholar
• 8 Nicholson A A, Ettles D F, Paddon A J, Dyet J F. Long-term follow-up of the Bird's Nest IVC filter.  Clin Radiol . 1999;  54 759-764
  CrossrefPubMedGoogle Scholar
• 9 Streiff M B. Vena caval filters: a comprehensive review.  Blood . 2000;  95(12) 3669-3677
  PubMedGoogle Scholar
• 10 White R H, Zhou H, Kim J, Romano P S. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.  Arch Intern Med . 2000;  160 2033-2041
  CrossrefPubMedGoogle Scholar
• 11 Crochet D P, Stora O, Ferry D. Vena Tech-LGM filter: long-term results of a prospective study.  Radiology . 1993;  188(3) 857-860
  PubMedGoogle Scholar
• 12 Decousus H, Leizorovicz A, Parent F. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis.  N Engl J Med . 1998;  338(7) 409-415
  CrossrefPubMedGoogle Scholar
• 13 Haire W D. Vena caval filters for the prevention of pulmonary embolism.  N Engl J Med . 1998;  338(7) 463-464
  CrossrefPubMedGoogle Scholar
• 14 Greenfield L J, Proctor M C. Filter complications and their management.  Semin Vasc Surg . 2000;  13(3) 213-216
  PubMedGoogle Scholar
• 15 Blebea J, Wilson R, Waybill P. Deep venous thrombosis after percutaneous insertion of vena caval filters.  J Vasc Surg . 1999;  30(5) 821-829
  PubMedGoogle Scholar
• 16 Jones B T, Fink J A. A prospective comparison of the status of the deep venous system after treatment with intracaval interruption versus anticoagulation.  J Am Coll Surg . 1994;  178 220-222
  PubMedGoogle Scholar
• 17 Rogers F B, Strindberg G, Shackford S R. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients.  Arch Surg . 1998;  133 406-411
  CrossrefPubMedGoogle Scholar
• 18 Girard P, Tardy B, Decousus H. Inferior vena cava interruption: how and when?.  Annu Rev Med . 2000;  51 1-15
  CrossrefPubMedGoogle Scholar
• 19 Rodriguez J L, Lopez J M, Proctor M C. Early placement of prophylactic vena cava filters in injured patients at high risk for pulmonary embolism.  J Trauma . 1996;  40(5) 797-804
  CrossrefPubMedGoogle Scholar
• 20 Proctor M C. Indications for filter placement.  Semin Vasc Surg . 2000;  13(3) 194-198
  PubMedGoogle Scholar
• 21 Hyers T M, Agnelli G, Hurd R D. Antithrombotic therapy for venous thromboembolic disease.  Chest . 2001 (suppl 1);  119 (176S-193S)
  PubMedGoogle Scholar
• 22 Schilz R, Wirth J. Vena cava filters: expanding indications and practices.  Clin Pulm Med . 2000;  7(1) 41-47
  PubMedGoogle Scholar
• 23 Barritt D W, Jordan S C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial.  Lancet . 1960;  1 1309-1312
  PubMedGoogle Scholar
• 24 Monreal M, Ruiz J, Salvador R. Recurrent pulmonary embolism: a prospective study.  Chest . 1989;  95 976-979
  PubMedGoogle Scholar
• 25 Norris C S, Greenfield L J, Herrmann J B. Free-floating ileofemoral thrombus: a risk of pulmonary embolism.  Arch Surg . 1985;  120 806-808
  PubMedGoogle Scholar
• 26 Pacouret G, Alison D, Pottier J, Bertrand P, Charbonnier B. Free-floating thrombus and embolic risk in patients with angiographically confirmed deep venous thrombosis. A prospective study.  Arch Int Med . 1997;  157 305-308
  PubMedGoogle Scholar
• 27 Cohen J R, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer.  Surgery . 1991;  109(1) 12-15
  PubMedGoogle Scholar
• 28 Cohen J R, Grella L, Citron M. Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer.  Cancer . 1992;  70(7) 1993-1996
  PubMedGoogle Scholar
• 29 Fink J A, Jones B T. The Greenfield filter as the primary means of therapy in venous thromboembolic disease.  Surg Gynecol Obstet . 1991;  172(4) 253-256
  PubMedGoogle Scholar
• 30 Ihnat D M, Mills J L, Hughes J D, Gentile A T, Berman S S, Westerband A. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?.  J Vasc Surg . 1998;  28(5) 800-807
  PubMedGoogle Scholar
• 31 Levin J M, Schiff D, Loeffler J S, Fine H A, Black P M, Wen P Y. Complications of therapy for venous thromboembolic disease in patients with brain tumors.  Neurology . 1993;  43 1111-1114
  CrossrefPubMedGoogle Scholar
• 32 Sarasin F P, Eckman M H. Management of prevention of thromboembolic events in patients with cancer-related hypercoaguable states: a risky business.  J Gen Intern Med . 1993;  8 476-486
  PubMedGoogle Scholar
• 33 Schiff D, DeAngelis L M. Therapy of venous thromboembolism in patients with brain metastases.  Cancer . 1994;  73(2) 493-498
  CrossrefPubMedGoogle Scholar
• 34 Greenfield L J, Proctor M C, Michaels A J, Taheri P A. Prophylactic vena cava filters in trauma: the rest of the story.  J Vasc Surg . 2000;  32(3) 490-497
  CrossrefPubMedGoogle Scholar
• 35 Hughes G C, Smith T P, Eachempati S R, Vaslef S N, Reed R L. The use of a temporary vena caval interruption device in high risk trauma patients unable to receive standard thromboembolism prophylaxis.  J Trauma . 1999;  46(2) 246-249
  CrossrefPubMedGoogle Scholar
• 36 Khansarinia S, Dennis J W, Veldenz H C, Butcher J L, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients.  J Vasc Surg . 1995;  22 231-236
  CrossrefPubMedGoogle Scholar
• 37 Langan E M, Miller R S, Casey W J, Carsten C G, Graham R M, Taylor S M. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment.  J Vasc Surg . 1999;  30(3) 484-490
  CrossrefPubMedGoogle Scholar
• 38 McMurtry A L, Owings J T, Anderson J T, Battistella F D, Gosselin R. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism.  J Am Coll Surg . 1999;  189(3) 314-320
  CrossrefPubMedGoogle Scholar
• 39 Velmahos G C, Oh Y, McCombs J, Oder D. An evidence-based cost effectiveness model on methods of prevention of posttraumatic venous thromboembolism.  J Trauma . 2000;  49(6) 1059-1064
  PubMedGoogle Scholar
• 40 Velmahos G C, Kern J, Chan L S, Oder D, Murray J A, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report-Part II: analysis of risk factors and evaluation of the role of vena caval filters.  J Trauma . 2000;  49 140-144
  CrossrefPubMedGoogle Scholar
• 41 Agnelli G. Venous thromboembolism and cancer: a two-way clinical association.  Thromb Haemost . 1997;  78 117-120
  PubMedGoogle Scholar
• 42 Krauth D, Holden A, Knapic N, Liepman M, Ansell J. Safety and efficacy of long-term oral anticoagulation in cancer patients.  Cancer . 1987;  59 983-985
  PubMedGoogle Scholar
• 43 Geerts W H, Code K I, Jay R M, Chen E, Szalai J P. A prospective study of venous thromboembolism after major trauma.  N Engl J Med . 1994;  331(24) 1601-1606
  CrossrefPubMedGoogle Scholar
• 44 Velmahos G C, Kern J, Chan L S, Oder D, Murray J A, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report-Part I: Analysis of risk factors and evaluation of the role of vena cava filters.  J Trauma . 2000;  49(1) 132-139
  CrossrefPubMedGoogle Scholar
• 45 Geerts W H, Jay R M, Code K I. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.  N Engl J Med . 1996;  335(10) 701-707
  CrossrefPubMedGoogle Scholar
• 46 Linsenmaier U, Rieger J, Schenk F, Rock C, Mangel E, Pfeifer K J. Indications, management, and complications of temporary inferior vena cava filters.  Cardiovasc Intervent Radiol . 1998;  21 464-469
  CrossrefPubMedGoogle Scholar